Best Immunotherapy with Keytruda (Pembolizumab) doctors in Israel: TOP 23 doctors

Principal investigator of clinical trials in cancer therapies – Dr. Sarid brings cutting-edge immunotherapy expertise to Sourasky Medical Center.

• Senior oncologist at Ichilov since 2009 with 38 years of experience in cancer treatment
• Specializes in biological cancer therapy including Keytruda applications
• Oxford-trained in cancer urology with 30+ published research articles
• Active member of ESMO and ASCO – global oncology standards

Dr. Pelles Sharon specializes in immunotherapy with Keytruda at Sourasky Medical Center, bringing extensive research and clinical expertise to cancer treatment.

• Conducted significant research on patient attitudes towards clinical trials
• Offers a wide range of advanced cancer treatments
• Experienced in various surgical and non-surgical oncology procedures
• Works at one of Israel's leading medical centers

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – a pioneer in immunotherapy research for sarcoma.

• Over 41 years of experience specializing in sarcoma and immunotherapy treatments
• ESMO faculty member for sarcoma treatment protocols
• Published extensively on immunotherapy outcomes in bone cancers
• Fellowship-trained at Institut Gustave Roussy – Europe's leading sarcoma center

Dr. Ram Ron specializes in Immunotherapy with Keytruda (Pembrolizumab) at Sourasky Medical Center (Ichilov), offering advanced treatment options.

• Special interests include cutting-edge immunotherapy treatments
• Practices at a leading medical center known for oncology
• Focused on patient-centered care with personalized treatment plans

300+ bone marrow and umbilical blood transplantations performed – Dr. El Hasid leads pediatric oncohematology at Dana Dwek Children's Hospital.

• Head of Pediatric Oncohematology and Oncology Department
• Member of American Association for Hematology
• 50+ publications and 40 conference reports
• Trained at City of Hope Hospital in Los Angeles

Dr. Ron Ram has performed several hundred stem cell transplants and published over 30 scientific articles, showcasing his deep expertise in oncology.

• Board-certified in Internal Medicine, Hematology, and Medical Oncology
• Fellowship-trained at New York Medical College, Westchester Medical Center
• Published a chapter in a medical textbook
• Works at Sourasky Medical Center (Ichilov)

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Leading researcher in immunotherapy trials – Dr. Raphael specializes in Keytruda (Pembrolizumab) at Sourasky Medical Center.

• Principal investigator for Keytruda clinical trials in NSCLC
• Expert in genomic profiling and liquid biopsies for treatment response
• Member of International Association for the Study of Lung Cancer
• Outstanding teacher recognized by Tel-Aviv University

Head of Medical Oncology at Sourasky Medical Center – Dr. Wolf leads a top-tier oncology division specializing in advanced treatments.

• Specializes in oncology with extensive experience in immunotherapy
• Degree from Ben Gurion University – trained in cutting-edge oncology protocols
• Fluent in English for clear patient communication
• Background includes Army Medical Units – handles complex cases

Head of Neurooncology Clinic at Sourasky Medical Center (Ichilov) – specializes in advanced cancer treatments.

• Leads a dedicated team for neurooncology cases
• Focuses on innovative therapies like immunotherapy
• Works at one of Israel's top medical centers

Director of oncology hospitalization at Tel Aviv Medical Center, Ichilov – Dr. Stepfansky brings extensive clinical and research expertise to immunotherapy cases.

• Over 26 years of experience of experience in oncology and internal medicine
• Actively involved in Phase I-III clinical trials for new cancer treatments
• Specialized training in oncology from Tel Aviv Medical Center, Ichilov
• Holds multiple research roles in cutting-edge immunotherapy studies

Dr. Fredi Aviv brings 34 years of experience of oncohematology expertise to immunotherapy treatments at Sourasky Medical Center (Ichilov Clinic).

• Specializes in hematologic oncology and immunotherapy
• Practices at a leading medical center in Israel
• Extensive experience with cutting-edge cancer treatments

Director of children's hematology oncology at Sourasky Medical Center, specializing in bone cancer (sarcoma) and blood disorders.

• Senior pediatrician at Children's Hospital 'Dana'
• Specializes in pediatric hematology and oncology
• Member of the Israeli association ISPHO
• Studied oncology bone and soft tissue in Italy's Rizzoli Orthopaedic Institute

Dr. Yair specializes in hematology with a focus on chronic lymphocytic leukemia – recognized with multiple awards for his research and clinical excellence.

• Recipient of the Klitzberg Oncology Award and other prestigious honors
• Member of both Israeli and American Hematology Associations
• Trained at top medical centers in Israel
• Published extensively in hematology research

Dr. Sonnenblick Amir specializes in targeted therapies for breast cancer, including immunotherapy with Keytruda (Pembolizumab). He's recognized with multiple awards for his contributions to oncology research.

• ESMO Breast Cancer Translational and Clinical Research Fellowship at Jules Bordet Institute
• Over 30 presentations at national and international scientific meetings
• Recipient of the ESMO Breast Cancer Translational Research Award
• Member of European Society of Medical Oncology (ESMO)

Dr. Auala Hubert brings 36 years of experience of expertise in oncology and radiotherapy at Hadassah Medical Center, specializing in immunotherapy.

• Heads the Gastrointestinal Cancer Center – deep expertise in complex cases
• Trained at Hadassah University Hospital – one of Israel's leading oncology centers
• Active member of multiple cancer research and treatment committees

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.